Hi Rasmus raises $50m from Updata Partners to scale autism care platform
Hi Rasmus, a Nashville-based clinical technology platform built for applied behaviour analysis (ABA) and broader behavioural health providers, has secured a $50 million strategic minority investment from Washington DC-based growth equity firm Updata Partners. Founders retain majority ownership, and Updata General Partner Braden Snyder will join the company's board of directors.
The company says it currently supports more than 1,000 customer organisations across all 50 US states and 90 countries, and that its platform logs over 19.6 million hours of client sessions annually. Two of what the company describes as the world's largest ABA providers are in the process of onboarding, though neither is named in the release. Hi Rasmus was founded in Denmark in 2021 by Nikolaj Hendriksen, whose personal experience navigating autism care for his son, Rasmus, shaped the product's clinical focus.
The deal
The platform combines clinical data collection, care-delivery workflows, scheduling, outcomes reporting and AI-assisted tools in what the company positions as an ABA-native, multidisciplinary-capable system. Hendriksen said the investment will allow the company to accelerate without abandoning its founding culture. "Updata gives us an experienced partner who can help us move faster, invest more deeply in innovation, and bring that impact to far more providers, schools, clinicians, families, and ultimately the children they serve," he said.
Updata's Snyder described Hi Rasmus as having "extraordinary growth" and "a clear vision for how technology can improve autism care," and said the firm views it as a potential "defining platform" in the market. The release did not disclose a post-money valuation, ARR figures, or the specific deal structure beyond the minority characterisation.
Market context
The behavioural health technology sector has attracted significant venture and growth capital over the past three years, driven by sustained demand for autism spectrum disorder services, a shortage of qualified clinicians, and a regulatory push in the United States toward value-based care and outcomes measurement. ABA-specific software competes with broader EHR platforms such as Rethink, CentralReach and Therapy Brands, all of which have themselves been targets of private equity consolidation.
The addition of AI-assisted clinical tools is becoming table stakes in the segment, with vendors racing to automate session notes, flag anomalies in outcomes data and reduce the documentation overhead that contributes to practitioner burnout. For a company with an international footprint spanning 90 countries, interoperability with local health information standards will also be a growing consideration.
Regulatory and compliance context
In the US, ABA platforms handling protected health information are subject to HIPAA, and any AI-generated clinical decision support could face additional scrutiny under forthcoming Office of the National Coordinator for Health Information Technology guidance on algorithmic transparency in health software. The EU AI Act's obligations for high-risk AI systems in health contexts will also apply to the company's European operations as those provisions mature, given its Danish origins and international reach.
Updata Partners manages more than $3 billion in committed capital and focuses on high-growth B2B software. The firm's involvement signals institutional confidence in the commercial scalability of mission-driven health software, a segment that has historically struggled to reconcile impact metrics with the revenue growth profiles that growth equity investors require. Hi Rasmus's next milestones to watch will be the completion of its two large-provider onboardings and any move toward publishing peer-reviewed clinical outcomes data to substantiate its evidence-based care claims.